APA (7th ed.) Citation

Yamazaki, K., Kubara, K., Ishii, S., Kondo, K., Suzuki, Y., Miyazaki, T., . . . Tsukahara, K. (2023). Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice. Molecular therapy. Nucleic acids, 33, 210-226. https://doi.org/10.1016/j.omtn.2023.06.023

Chicago Style (17th ed.) Citation

Yamazaki, Kazuto, Kenji Kubara, Satoko Ishii, Keita Kondo, Yuta Suzuki, Takayuki Miyazaki, Kaoru Mitsuhashi, Masashi Ito, and Kappei Tsukahara. "Lipid Nanoparticle-targeted MRNA Formulation as a Treatment for Ornithine-transcarbamylase Deficiency Model Mice." Molecular Therapy. Nucleic Acids 33 (2023): 210-226. https://doi.org/10.1016/j.omtn.2023.06.023.

MLA (9th ed.) Citation

Yamazaki, Kazuto, et al. "Lipid Nanoparticle-targeted MRNA Formulation as a Treatment for Ornithine-transcarbamylase Deficiency Model Mice." Molecular Therapy. Nucleic Acids, vol. 33, 2023, pp. 210-226, https://doi.org/10.1016/j.omtn.2023.06.023.